about
Pharmacotherapy of vestibular and ocular motor disorders, including nystagmusRod-cone dystrophy in spinocerebellar ataxia type 1.Nystagmus and saccadic intrusions.Transverse sinus stenting for idiopathic intracranial hypertension: a review of 52 patients and of model predictions.Crossover trial of gabapentin and memantine as treatment for acquired nystagmus.Pharmacological tests of hypotheses for acquired pendular nystagmusThe Pattern of Visual Fixation Eccentricity and Instability in Optic Neuropathy and Its Spatial Relationship to Retinal Ganglion Cell Layer Thickness.Perimetric evaluation of saccadic latency, saccadic accuracy, and visual threshold for peripheral visual stimuli in young compared with older adultsOptic nerve head drusen in black patients.Causes and Prognosis of Visual Acuity Loss at the Time of Initial Presentation in Idiopathic Intracranial Hypertension.Miller Fisher syndrome mimicking ocular myasthenia gravis.Neurological basis for eye movements of the blind.Disorders of saccades.Nonarteritic anterior ischemic optic neuropathy with PDE-5 inhibitors for erectile dysfunction.Effect of vergence on human ocular following response (OFR)Limited Wegener's Granulomatosis Presenting with an Isolated Abduction DeficitEvaluation of optic neuropathy in multiple sclerosis using low-contrast visual evoked potentialsBilateral jugular paragangliomas: a rare cause of raised intracranial pressure.Eye movements in amyotrophic lateral sclerosis and its mimics: a review with illustrative cases.Third nerve palsy as the initial manifestation of giant cell arteritis.Diagnostic approach to abnormal spontaneous eye movements.Treatment of Nystagmus.The Yield of Diagnostic Imaging in Patients with Isolated Horner Syndrome.Three-dimensional kinematics of saccadic and pursuit eye movements in humans: relationship between Donders' and Listing's lawsThree-dimensional kinematics of saccadic eye movements in humans with cerebellar degeneration.Bilateral septic cavernous sinus thrombosis, congestive orbitopathy, and ischemic optic neuropathy.Evidence for three-dimensional cortical control of gaze from epileptic patients.Identification of Herpes Zoster-Associated Temporal Arteritis Among Cases of Giant Cell Arteritis.Optic disc haemorrhages at baseline as a risk factor for poor outcome in the Idiopathic Intracranial Hypertension Treatment Trial.The Longitudinal Idiopathic Intracranial Hypertension Trial: Outcomes From Months 6-12.Isolated sixth cranial nerve palsy in preeclampsia.Visual Fixation Instability in Multiple Sclerosis Measured Using SLO-OCT.Monocular ophthalmoplegia and partial supranuclear vertical gaze palsy due to unilateral paramedian rostral midbrain infarction.Treatment of nystagmus.Pituitary apoplexy causing isolated blindness after cardiac bypass surgery.TREATMENT OF RETINOPATHY AND MACULAR EDEMA SECONDARY TO A CAROTID-CAVERNOUS FISTULA.Visual loss without papilledema in idiopathic intracranial hypertension.Vertical eye position-dependence of the human vestibuloocular reflex during passive and active yaw head rotationsThe human horizontal vestibulo-ocular reflex in response to active and passive head impulses after unilateral vestibular deafferentationTuberculous cranial pachymeningitis
P50
Q24595123-F06E2440-A925-4D90-BB51-F911D266DA2CQ33575517-76CCADB9-DA9D-4367-8635-C6844D395717Q33907589-8EA309A3-BC7E-4192-84BA-E7028012628DQ34204439-7AA73C9D-6941-4D7C-BDEA-939ADDB150D7Q34722007-E851E27B-BF1D-4A8C-ABD1-E788055A5DE3Q35278618-3C23B82B-A286-4B4E-BDEA-7E4A44DFF338Q36074877-588A2AA4-A4AF-4415-BA26-900D0245D081Q36115566-764CA149-81F5-4E00-8A3A-F6E22C90366AQ36281929-837FDE3D-57B2-4950-BCF6-CD297B3F5EFAQ36420646-CB2DBEBA-7F90-44BA-B1C3-2458922FFCB3Q36451078-FB381238-02A5-4CC8-BBCF-89D81D19D515Q36618796-CA4ED2C6-9098-414B-8614-AC39CBDF2CE3Q36926053-F0DD3418-8023-46BA-8FA8-5ECDD8B23242Q37182743-DC7183AC-1D5F-474D-8976-BF1DCCF71064Q37265856-F05564F6-1173-4F7C-AC9C-2B96242AFEFEQ37439340-E3B7EDF3-E156-4D8F-8416-EE30E99BC992Q37459686-EF327A34-2288-496F-BFC4-070CEE3E2E88Q37623217-805D7E78-9DE3-4852-9C4E-7EFA64A2FA23Q37811613-8F77E8C6-CC4C-43F6-A988-7D472414E3A7Q38199332-DB4A1C67-553E-4765-98BB-DD347F6CF4B0Q38237507-445F2A2B-07F9-4AEF-BAA7-0608C9369D12Q38601358-3F7E4FAA-15D4-40CF-B541-B8BF7B830E5CQ39019829-F901CB26-49AA-41D2-8ADE-2DB4D638BC44Q41791369-854A5F53-8E5C-4271-BAF9-B71D405C4586Q43755883-16F6E853-6F84-480E-AFFB-47626DB976CEQ44218997-62A39169-4F9D-4A89-ABE2-FF5CA6E69052Q46008508-78E54850-C911-4020-AEAA-E21811ADDB1BQ47182000-561C559A-F6AB-451E-B0CF-3D50F524198CQ47583547-D52ED6D4-D106-426A-B353-40B5376F18F4Q47587782-D978FD66-19DA-4314-8AB2-193850475044Q48318357-07ED5CEB-A98A-49BC-86E3-AAF6F3E09393Q48507150-B0D62CBC-19FB-4293-980A-9A13F2371172Q48614742-9CEB1B71-A125-49B9-8E82-7B9D404AEFEBQ50262029-4D158AF9-09C7-4629-9AE0-82141B12F7A6Q53422890-53640FB0-4710-4A8A-AD24-70E479C73DE5Q55037352-8520E31B-8CA5-41C1-9A9F-9A97E9016956Q64983223-0135D9EF-CEBB-457A-804B-962705E2EDF5Q77734826-E95818CB-0BFB-4096-9CEC-47E853065F2BQ79353590-0AD77E9A-7324-4A88-A7EE-86956AD53867Q79622669-439B3B76-2799-46A5-BE52-5F5ED9450A46
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Matthew J Thurtell
@ast
Matthew J Thurtell
@en
Matthew J Thurtell
@es
Matthew J Thurtell
@nl
type
label
Matthew J Thurtell
@ast
Matthew J Thurtell
@en
Matthew J Thurtell
@es
Matthew J Thurtell
@nl
prefLabel
Matthew J Thurtell
@ast
Matthew J Thurtell
@en
Matthew J Thurtell
@es
Matthew J Thurtell
@nl
P106
P1153
6506532130
P31
P496
0000-0002-1546-5463